Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 25 peer-reviewed journal articles Updated

Can You Get COPD If You Have Never Smoked? Causes Explained

At a Glance

Yes. COPD can develop in people who have never smoked because of secondhand smoke, indoor air pollution, workplace dust or fumes, asthma, or alpha-1 antitrypsin deficiency. A breathing test called spirometry confirms ongoing airflow blockage and helps rule out other causes.

In this answer

2 sections

01

Possible Contributors to Non-Smoker COPD

02

The Importance of an Accurate Diagnosis

Yes, you can develop chronic obstructive pulmonary disease (COPD) without ever smoking a cigarette. If you have never smoked and have been diagnosed with COPD, your diagnosis is not impossible, and it is not your fault.

Estimates vary depending on the country and how COPD is defined, but never-smokers account for an estimated 25% to 45% of COPD cases worldwide [1]. In certain regions with high environmental exposures, such as parts of China, studies have found that up to 41% of people with COPD have never smoked [2].

While tobacco smoke is the most common cause of COPD, your lungs can be damaged by other inhaled irritants, genetic factors, and childhood illnesses. Understanding the non-tobacco causes of COPD can help you and your doctor build a personalized and effective care plan.

Possible Contributors to Non-Smoker COPD

A careful review of your medical and environmental history can often identify possible contributors to your lung damage. Often, more than one factor is involved. The primary contributors to COPD and chronic airflow obstruction in non-smokers include:

  • Secondhand smoke: Breathing in other people’s tobacco smoke, whether during childhood or as an adult, significantly increases your risk of developing COPD [3][4].
  • Biomass and indoor air pollution: Cooking or heating your home with solid fuels—such as wood, coal, or animal dung—in poorly ventilated spaces is a major contributor to COPD globally [5][4][6].
  • Occupational dusts and fumes: Workplace exposure to industrial vapors, gases, dusts, or chemical fumes increases the risk of COPD, even in never-smokers [7][8].
  • Impaired lung development: Factors that keep your lungs from growing to their full capacity—such as prematurity, low birth weight, or severe childhood respiratory infections—are risk factors for reduced lung function and chronic airflow limitation later in life [9][10].
  • Asthma: Asthma is typically characterized by variable airway narrowing. However, long-standing or severe asthma can lead to permanent, fixed airway obstruction. Asthma and COPD can also coexist in the same person [11][12].
  • Prior infections: A history of severe lung infections, such as tuberculosis, can cause lasting structural damage to the lungs. This can lead to chronic airflow limitation that may be labeled as COPD or exist as a distinct post-infectious lung disease [13][12].
  • Alpha-1 antitrypsin (AAT) deficiency: This is a genetic condition where your body produces either an insufficient amount or an abnormal, poorly functioning form of a protective protein. This can lead to lung inflammation and sometimes liver problems [14][15]. Medical guidelines recommend that all people diagnosed with COPD be tested for this genetic factor at least once, regardless of their smoking history. An abnormal initial screening may require further genetic testing [14][16].

The Importance of an Accurate Diagnosis

Because COPD is heavily associated with smoking, non-smokers with breathing issues are sometimes misdiagnosed, or their symptoms might be dismissed. Alternatively, doctors might assume a non-smoker has COPD without considering other conditions.

To confirm a COPD diagnosis, you must undergo a specific breathing test called spirometry [17][18]. Spirometry measures how much air you can exhale and how fast you can blow it out. For a diagnosis of COPD, this test must be performed before and after you inhale a bronchodilator (a medicine that opens your airways) [18].

The test must show persistent airflow obstruction. Guidelines often define this as an FEV1/FVC ratio (the proportion of air you can blow out in one second compared to your total breath) of less than 0.70 [19][20]. However, this fixed number can sometimes overdiagnose older adults and underdiagnose younger ones, so some doctors use a threshold called the “lower limit of normal” based on your age and height [21]. If your results are borderline, the test may need to be repeated [17][18].

Ruling Out COPD “Mimics”

Your doctor should not assume you have COPD without first considering other conditions that cause similar symptoms, such as chronic cough and shortness of breath [17]. These “mimics” include:

  • Asthma: While asthma and COPD are distinct, they can overlap. Doctors look at your symptom history, triggers, and repeated testing rather than relying on a single breathing test to tell them apart [22][23].
  • Bronchiectasis: This condition involves permanently widened and damaged airways. Common symptoms can include a daily wet cough and frequent chest infections, though symptoms vary from person to person [24][25].
  • Heart disease: Heart failure can cause shortness of breath and fluid buildup in the lungs, which might easily be mistaken for a respiratory disease [17].

(Note: Seek urgent medical attention if you experience severe or rapidly worsening breathlessness, confusion, severe chest pain, or a blue/gray tint to your lips or nails, as these are medical emergencies.)

Common questions in this guide

Can someone who has never smoked still develop COPD?
Yes. COPD can develop in people who have never smoked because of secondhand smoke, indoor or workplace pollutants, asthma, previous lung infections, impaired lung development, or alpha-1 antitrypsin deficiency. Smoking is the most common cause, but it is not the only one.
What causes COPD in people who do not smoke?
Important contributors include secondhand smoke; cooking or heating with wood, coal, or animal dung in poorly ventilated spaces; and workplace dusts, gases, vapors, or chemical fumes. Severe asthma, childhood lung problems, previous infections such as tuberculosis, and alpha-1 antitrypsin deficiency may also contribute. More than one factor can be involved.
How is COPD confirmed if I have never smoked?
COPD is confirmed with spirometry, a breathing test performed before and after a bronchodilator, which is a medicine that opens the airways. The test looks for airflow obstruction that persists after the medicine; doctors may use age- and height-based normal ranges and repeat the test if results are borderline.
Could asthma or another illness be mistaken for COPD?
Yes. Asthma, bronchiectasis, and heart failure can cause cough or shortness of breath and may resemble COPD. Doctors use your symptom pattern, medical history, breathing tests, and sometimes imaging to distinguish them, and asthma and COPD can occur together.
Should I be tested for alpha-1 antitrypsin deficiency if I have COPD?
Medical guidelines recommend testing everyone diagnosed with COPD for alpha-1 antitrypsin deficiency at least once, whether or not they have smoked. If the initial blood test is abnormal, additional genetic testing may be needed.
Which exposures should I discuss with my doctor?
Discuss regular exposure to secondhand smoke, wood or coal fires, animal-dung fuel, poor ventilation, and dusts, vapors, gases, or chemical fumes at work. Also mention severe asthma, childhood lung problems, and prior infections, because identifying contributors can help guide evaluation and exposure reduction.

Related questions

When Are Oral Steroids Used for COPD? Side Effects Explained What Does a Low DLCO Indicate in COPD? Causes Explained When Are Antibiotics Needed for a COPD Exacerbation? What Does FEV1 Percent Predicted Mean for COPD Prognosis? What Is a Mild, Moderate, or Severe COPD Exacerbation?
Show more
Why Do COPD Flare-Ups Keep Happening? How to Prevent Them How Often Should Spirometry Be Repeated for COPD Monitoring? Is COPD Reversible? Can Treatment Restore Lung Function? Should COPD Patients Get Low-Dose CT Lung Cancer Screening? What Does a Low Alpha-1 Antitrypsin Test Mean for COPD? How Is the BODE Index Calculated and Interpreted in COPD? How Is a Severe COPD Exacerbation Treated in the Hospital? What Happens If I Have Asthma and COPD Together? Explained Why Can COPD Be GOLD Grade 2 and Still Be Group E? Can Borderline Spirometry Confirm COPD? When to Repeat? What Are COPD-Related PH and Cor Pulmonale Symptoms? What Should a Written COPD Exacerbation Action Plan Include? Do I Need a Chest CT, Chest X-ray, or DLCO Test for COPD? What Comorbidities Should COPD Checkups Screen For?

Get notified when new evidence is published on chronic obstructive pulmonary disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (25)
  1. 1

    Epidemiology of Chronic Obstructive Pulmonary Disease.

    Ruvuna L, Sood A

    Clinics in chest medicine 2020; (41(3)):315-327 doi:10.1016/j.ccm.2020.05.002.

    PMID: 32800187
  2. 2

    Prevalence of non-smoking chronic obstructive pulmonary disease and its risk factors in China: a systematic review and meta-analysis.

    Zhang Y, Gai X, Chu H, et al.

    BMC public health 2024; (24(1)):3010 doi:10.1186/s12889-024-20170-z.

    PMID: 39478509
  3. 3

    Secondhand smoke increases the risk of developing chronic obstructive pulmonary disease.

    Su WC, Juan HL, Lee JI, et al.

    Scientific reports 2024; (14(1)):7481 doi:10.1038/s41598-024-58038-2.

    PMID: 38553570
  4. 4

    Chronic obstructive Pulmonary Disease (COPD) in non-smoking Sri Lankan adults; a cross-sectional study.

    Gunasekera KD, Amarasiri W, Wickremasinghe AR, et al.

    BMC research notes 2025; (18(1)):84 doi:10.1186/s13104-025-07146-x.

    PMID: 40001249
  5. 5

    Prevalence of chronic obstructive pulmonary disease in Indian nonsmokers: a systematic review & meta-analysis.

    Suri TM, Ghosh T, Mittal S, et al.

    Reviews on environmental health 2025; (40(1)):11-20 doi:10.1515/reveh-2023-0135.

    PMID: 38016010
  6. 6

    Risk of COPD due to indoor air pollution from biomass cooking fuel: a systematic review and meta-analysis.

    Pathak U, Gupta NC, Suri JC

    International journal of environmental health research 2020; (30(1)):75-88 doi:10.1080/09603123.2019.1575951.

    PMID: 30754998
  7. 7

    Prevalence and risk factors of COPD among never-smokers in two areas of Sweden - Occupational exposure to gas, dust or fumes is an important risk factor.

    Hagstad S, Backman H, Bjerg A, et al.

    Respiratory medicine 2015; (109(11)):1439-45.

    PMID: 26440676
  8. 8

    Risk factors for chronic obstructive pulmonary disease among never-smokers in Korea.

    Lee SJ, Kim SW, Kong KA, et al.

    International journal of chronic obstructive pulmonary disease 2015; (10()):497-506 doi:10.2147/COPD.S77662.

    PMID: 25784796
  9. 9

    Impact of early life exposures on COPD in adulthood: A systematic review and meta-analysis.

    Duan P, Wang Y, Lin R, et al.

    Respirology (Carlton, Vic.) 2021; (26(12)):1131-1151 doi:10.1111/resp.14144.

    PMID: 34541740
  10. 10

    Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment.

    Yang IA, Jenkins CR, Salvi SS

    The Lancet. Respiratory medicine 2022; (10(5)):497-511 doi:10.1016/S2213-2600(21)00506-3.

    PMID: 35427530
  11. 11

    Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma.

    McGeachie MJ, Yates KP, Zhou X, et al.

    The New England journal of medicine 2016; (374(19)):1842-1852 doi:10.1056/NEJMoa1513737.

    PMID: 27168434
  12. 12

    Prevalence and Population-Attributable Risk for Chronic Airflow Obstruction in a Large Multinational Study.

    Burney P, Patel J, Minelli C, et al.

    American journal of respiratory and critical care medicine 2021; (203(11)):1353-1365 doi:10.1164/rccm.202005-1990OC.

    PMID: 33171069
  13. 13

    Chronic Airflow Obstruction in a Black African Population: Results of BOLD Study, Ile-Ife, Nigeria.

    Obaseki DO, Erhabor GE, Gnatiuc L, et al.

    COPD 2016; (13(1)):42-9 doi:10.3109/15412555.2015.1041102.

    PMID: 26451840
  14. 14

    Alpha-1-Antitrypsin Deficiency Targeted Testing and Augmentation Therapy: A Canadian Thoracic Society Meta-Analysis and Clinical Practice Guideline.

    Hernandez P, Bossé Y, Bush P, et al.

    Chest 2025; (167(4)):1044-1063 doi:10.1016/j.chest.2024.08.037.

    PMID: 39880301
  15. 15

    Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis.

    Greulich T, Vogelmeier CF

    Therapeutic advances in respiratory disease 2016; (10(1)):72-84 doi:10.1177/1753465815602162.

    PMID: 26341117
  16. 16

    Spanish Clinical Practice Guidelines for the Diagnosis and Management of Alpha-1 Antitrypsin Deficiency: 2026 Update.

    Calle Rubio M, López-Campos JL, Casas Maldonado F, et al.

    Archivos de bronconeumologia 2026; doi:10.1016/j.arbres.2026.06.004.

    PMID: 42392940
  17. 17

    Under- and over-diagnosis of COPD: a global perspective.

    Ho T, Cusack RP, Chaudhary N, et al.

    Breathe (Sheffield, England) 2019; (15(1)):24-35 doi:10.1183/20734735.0346-2018.

    PMID: 30838057
  18. 18

    GOLD Science Committee recommendations for the use of pre- and post-bronchodilator spirometry for the diagnosis of COPD.

    Singh D, Stockley R, Anzueto A, et al.

    The European respiratory journal 2025; (65(2)) doi:10.1183/13993003.01603-2024.

    PMID: 39638416
  19. 19

    The Effect of a Post-Bronchodilator FEV1/FVC < 0.7 on COPD Diagnosis and Treatment: A Regression Discontinuity Design.

    Moffett AT, Halpern SD, Weissman GE

    medRxiv : the preprint server for health sciences 2024; doi:10.1101/2024.08.05.24311519.

    PMID: 39148856
  20. 20

    Importance of distinguishing between asthma and chronic obstructive pulmonary disease in primary care.

    D'Urzo AD, Price D, Kardos P, Maleki-Yazdi MR

    Canadian family physician Medecin de famille canadien 2021; (67(9)):661-667 doi:10.46747/cfp.6709661.

    PMID: 34521707
  21. 21

    Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality.

    Bhatt SP, Balte PP, Schwartz JE, et al.

    JAMA 2019; (321(24)):2438-2447 doi:10.1001/jama.2019.7233.

    PMID: 31237643
  22. 22

    Primary Care of the Patient with Asthma.

    Lenaeus MJ, Hirschmann J

    The Medical clinics of North America 2015; (99(5)):953-67.

    PMID: 26320041
  23. 23

    Identifying possible asthma-COPD overlap syndrome in patients with a new diagnosis of COPD in primary care.

    Baarnes CB, Kjeldgaard P, Nielsen M, et al.

    NPJ primary care respiratory medicine 2017; (27()):16084 doi:10.1038/npjpcrm.2016.84.

    PMID: 28055002
  24. 24

    Bronchiectasis-COPD Overlap Syndrome: A Comprehensive Review of its Pathophysiology and Potential Cardiovascular Implications.

    Alam MA, Mangapuram P, Fredrick FC, et al.

    Therapeutic advances in pulmonary and critical care medicine 2024; (19()):29768675241300808 doi:10.1177/29768675241300808.

    PMID: 39655338
  25. 25

    Tuberculosis and chronic respiratory disease: a systematic review.

    Byrne AL, Marais BJ, Mitnick CD, et al.

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2015; (32()):138-46.

    PMID: 25809770

This page is for informational purposes only and does not constitute medical advice. A healthcare professional can evaluate your symptoms, exposures, and test results to determine the right diagnosis and care.